ATE369150T1 - Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe - Google Patents
Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabeInfo
- Publication number
- ATE369150T1 ATE369150T1 AT95941347T AT95941347T ATE369150T1 AT E369150 T1 ATE369150 T1 AT E369150T1 AT 95941347 T AT95941347 T AT 95941347T AT 95941347 T AT95941347 T AT 95941347T AT E369150 T1 ATE369150 T1 AT E369150T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- body surface
- compositions
- electrotransport
- active delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Electrotherapy Devices (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Centrifugal Separators (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/338,924 US5736580A (en) | 1994-11-14 | 1994-11-14 | Composition, device, and method for electrotransport agent delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE369150T1 true ATE369150T1 (de) | 2007-08-15 |
Family
ID=23326715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95941347T ATE369150T1 (de) | 1994-11-14 | 1995-11-01 | Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe |
Country Status (11)
Country | Link |
---|---|
US (3) | US5736580A (de) |
EP (1) | EP0789589B1 (de) |
JP (1) | JP4049389B2 (de) |
AT (1) | ATE369150T1 (de) |
CA (1) | CA2201725C (de) |
DE (1) | DE69535556T2 (de) |
DK (1) | DK0789589T3 (de) |
ES (1) | ES2292171T3 (de) |
HK (1) | HK1000450A1 (de) |
PT (1) | PT789589E (de) |
WO (1) | WO1996014869A1 (de) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6956032B1 (en) * | 1986-04-18 | 2005-10-18 | Carnegie Mellon University | Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
US8825152B2 (en) | 1996-01-08 | 2014-09-02 | Impulse Dynamics, N.V. | Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue |
US7167748B2 (en) | 1996-01-08 | 2007-01-23 | Impulse Dynamics Nv | Electrical muscle controller |
US8321013B2 (en) * | 1996-01-08 | 2012-11-27 | Impulse Dynamics, N.V. | Electrical muscle controller and pacing with hemodynamic enhancement |
JP4175662B2 (ja) | 1996-01-08 | 2008-11-05 | インパルス ダイナミクス エヌ.ヴイ. | 電気的筋肉制御装置 |
US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
US9713723B2 (en) | 1996-01-11 | 2017-07-25 | Impulse Dynamics Nv | Signal delivery through the right ventricular septum |
US5676648A (en) | 1996-05-08 | 1997-10-14 | The Aps Organization, Llp | Iontophoretic drug delivery apparatus and method for use |
US6385487B1 (en) | 1996-05-08 | 2002-05-07 | Biophoretic Therapeutic Systems, Llc | Methods for electrokinetic delivery of medicaments |
US6119036A (en) * | 1997-03-26 | 2000-09-12 | The Board Of Regents Of The University Of Oklahoma | Iontophoretic transdermal delivery device |
WO1999018797A1 (en) | 1997-10-09 | 1999-04-22 | Emory University | Method and devices for transdermal delivery of lithium |
EP0922467A3 (de) * | 1997-12-12 | 2000-05-24 | Takeda Chemical Industries, Ltd. | Iontophoretische Verabreichung von Medikamenten |
USRE37796E1 (en) | 1997-12-16 | 2002-07-23 | Biophoretic Therapeutic Systems, Llc | Methods for iontophoretic delivery of antiviral agents |
US6374136B1 (en) * | 1997-12-22 | 2002-04-16 | Alza Corporation | Anhydrous drug reservoir for electrolytic transdermal delivery device |
US6148231A (en) * | 1998-09-15 | 2000-11-14 | Biophoretic Therapeutic Systems, Llc | Iontophoretic drug delivery electrodes and method |
WO2006073671A1 (en) | 2004-12-09 | 2006-07-13 | Impulse Dynamics Nv | Protein activity modification |
US8666495B2 (en) | 1999-03-05 | 2014-03-04 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US8700161B2 (en) | 1999-03-05 | 2014-04-15 | Metacure Limited | Blood glucose level control |
US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
US8019421B2 (en) * | 1999-03-05 | 2011-09-13 | Metacure Limited | Blood glucose level control |
US6792306B2 (en) * | 2000-03-10 | 2004-09-14 | Biophoretic Therapeutic Systems, Llc | Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor |
US6477410B1 (en) * | 2000-05-31 | 2002-11-05 | Biophoretic Therapeutic Systems, Llc | Electrokinetic delivery of medicaments |
US7127285B2 (en) * | 1999-03-12 | 2006-10-24 | Transport Pharmaceuticals Inc. | Systems and methods for electrokinetic delivery of a substance |
DE19923427A1 (de) | 1999-05-21 | 2000-11-23 | Lohmann Therapie Syst Lts | Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen |
US7092753B2 (en) * | 1999-06-04 | 2006-08-15 | Impulse Dynamics Nv | Drug delivery device |
US7190997B1 (en) | 1999-06-04 | 2007-03-13 | Impulse Dynamics Nv | Drug delivery device |
US7171263B2 (en) * | 1999-06-04 | 2007-01-30 | Impulse Dynamics Nv | Drug delivery device |
US7069226B1 (en) | 1999-07-07 | 2006-06-27 | Synetic, Incorporated | Prescription data processing system for determining new therapy starts |
EP1246792B1 (de) * | 2000-01-13 | 2014-08-13 | Emisphere Technologies, Inc. | Verbindungen und zusammensetzung zur abgabe von wirkstoffen |
GB0017999D0 (en) | 2000-07-21 | 2000-09-13 | Smithkline Beecham Biolog | Novel device |
ATE359802T1 (de) * | 2002-10-04 | 2007-05-15 | Photokinetix Inc | Photokinetische abgabe von biologisch aktiven subtanzen unter verwendung von pulsierendem inkohaerentem licht. |
CN1787850B (zh) | 2003-03-10 | 2015-12-16 | 脉冲动力公司 | 用于传送电信号以修改心脏组织中基因表达的装置与方法 |
US11439815B2 (en) | 2003-03-10 | 2022-09-13 | Impulse Dynamics Nv | Protein activity modification |
US8792985B2 (en) | 2003-07-21 | 2014-07-29 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US8352031B2 (en) | 2004-03-10 | 2013-01-08 | Impulse Dynamics Nv | Protein activity modification |
US8548583B2 (en) | 2004-03-10 | 2013-10-01 | Impulse Dynamics Nv | Protein activity modification |
US11779768B2 (en) | 2004-03-10 | 2023-10-10 | Impulse Dynamics Nv | Protein activity modification |
US8296162B1 (en) | 2005-02-01 | 2012-10-23 | Webmd Llc. | Systems, devices, and methods for providing healthcare information |
US8244371B2 (en) | 2005-03-18 | 2012-08-14 | Metacure Limited | Pancreas lead |
US8380530B2 (en) | 2007-02-02 | 2013-02-19 | Webmd Llc. | Personalized health records with associative relationships |
US8197844B2 (en) | 2007-06-08 | 2012-06-12 | Activatek, Inc. | Active electrode for transdermal medicament administration |
US20090137925A1 (en) * | 2007-11-23 | 2009-05-28 | Divya Cantor | Impedance Spectroscopy Cervix Scanning Apparatus and Method |
US8862223B2 (en) | 2008-01-18 | 2014-10-14 | Activatek, Inc. | Active transdermal medicament patch and circuit board for same |
WO2011046927A1 (en) * | 2009-10-13 | 2011-04-21 | Nupathe,Inc. | Transdermal methods and systems for the delivery of rizatriptan |
WO2011092710A2 (en) | 2010-02-01 | 2011-08-04 | Metacure Limited | Gastrointestinal electrical therapy |
JP6243102B2 (ja) * | 2012-05-01 | 2017-12-06 | 株式会社ジェムインターナショナル | 貼付剤 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5084241A (en) * | 1982-09-20 | 1992-01-28 | V-Tech, Inc. | Apparatus including a sample petter tube for obtaining reproducible liquid samples of small volume |
US5128376A (en) * | 1983-07-01 | 1992-07-07 | Nitto Denko Corporation | Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator |
US4605670A (en) * | 1984-02-01 | 1986-08-12 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering metoclopramide |
US4722720A (en) * | 1985-04-30 | 1988-02-02 | Nhk Spring Co., Ltd. | Tension providing device |
US4722726A (en) * | 1986-02-12 | 1988-02-02 | Key Pharmaceuticals, Inc. | Method and apparatus for iontophoretic drug delivery |
DE3724691C2 (de) * | 1987-07-25 | 1999-03-18 | Konrad Minninger | Pharmazeutisches Mittel zur lokalen Therapie von schuppenden Hautkrankheiten |
WO1990008547A1 (de) * | 1989-01-25 | 1990-08-09 | Dr. August Wolff Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg | Salicylsäurehaltiges mittel gegen schuppende hauterkrankungen |
US5087242A (en) * | 1989-07-21 | 1992-02-11 | Iomed, Inc. | Hydratable bioelectrode |
US5023085A (en) * | 1989-11-29 | 1991-06-11 | Pfizer Inc. | Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
US5149719A (en) * | 1990-04-27 | 1992-09-22 | Minnesota Mining And Manufacturing Company | Composition for transdermal penetration of medicaments |
US5087241A (en) * | 1990-07-24 | 1992-02-11 | Empi, Inc. | Iontophoresis electrode with reservoir and injection site |
US5158537A (en) * | 1990-10-29 | 1992-10-27 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
ATE122245T1 (de) * | 1990-10-29 | 1995-05-15 | Alza Corp | Elektrode zur iontophoretischen verabreichung von medikamenten und verfahren zur hydratation derselben. |
ES2120477T3 (es) * | 1992-01-21 | 1998-11-01 | Macrochem Corp | Administracion iontoforetica de medicamentos perfeccionada. |
US5310404A (en) * | 1992-06-01 | 1994-05-10 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
JPH0616538A (ja) * | 1992-07-03 | 1994-01-25 | Japan Tobacco Inc | イオントフォレーゼのための薬物吸収用液組成物 |
-
1994
- 1994-11-14 US US08/338,924 patent/US5736580A/en not_active Expired - Lifetime
-
1995
- 1995-11-01 JP JP51610896A patent/JP4049389B2/ja not_active Expired - Fee Related
- 1995-11-01 PT PT95941347T patent/PT789589E/pt unknown
- 1995-11-01 EP EP95941347A patent/EP0789589B1/de not_active Expired - Lifetime
- 1995-11-01 ES ES95941347T patent/ES2292171T3/es not_active Expired - Lifetime
- 1995-11-01 WO PCT/US1995/014091 patent/WO1996014869A1/en active IP Right Grant
- 1995-11-01 AT AT95941347T patent/ATE369150T1/de active
- 1995-11-01 DK DK95941347T patent/DK0789589T3/da active
- 1995-11-01 DE DE69535556T patent/DE69535556T2/de not_active Expired - Lifetime
- 1995-11-01 CA CA002201725A patent/CA2201725C/en not_active Expired - Fee Related
-
1997
- 1997-10-08 HK HK97101906A patent/HK1000450A1/xx not_active IP Right Cessation
- 1997-12-05 US US08/985,542 patent/US5811465A/en not_active Expired - Lifetime
- 1997-12-05 US US08/985,511 patent/US6057374A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6057374A (en) | 2000-05-02 |
US5736580A (en) | 1998-04-07 |
WO1996014869A1 (en) | 1996-05-23 |
EP0789589B1 (de) | 2007-08-08 |
DE69535556D1 (de) | 2007-09-20 |
EP0789589A1 (de) | 1997-08-20 |
CA2201725A1 (en) | 1996-05-23 |
CA2201725C (en) | 2008-06-03 |
DK0789589T3 (da) | 2007-12-17 |
ES2292171T3 (es) | 2008-03-01 |
DE69535556T2 (de) | 2008-03-06 |
HK1000450A1 (en) | 2008-04-03 |
JPH10508849A (ja) | 1998-09-02 |
US5811465A (en) | 1998-09-22 |
JP4049389B2 (ja) | 2008-02-20 |
PT789589E (pt) | 2007-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE369150T1 (de) | Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe | |
DE69833000D1 (de) | Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen | |
EP1582210A3 (de) | Mittel und Verfahren zur Behandlung oder Vorbeugung der chirurgischen Adhäsionen | |
ATE224753T1 (de) | Vorrichtung zur verabreichung von medikamenten durch elektrotransport | |
ATE170769T1 (de) | Vorrichtung zur verabreichung von medikamenten durch elektrotransport | |
DE69623608D1 (de) | Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff | |
ATE114486T1 (de) | Verfahren und vorrichtung zur iontophoretischen abgabe von medikamenten. | |
EP1329225A3 (de) | Als löslichkeit-steigernde gebrauchte Polyvinylpyrrolidon enthaltende transdermale Vorrichtung | |
ATE261721T1 (de) | System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung | |
UA39172C2 (uk) | Похідні 2-(2,6-дигалофеніламіно) фенілоцтової кислоти і спосіб їх одержання | |
EP1336600A3 (de) | Dimer-selektive rxr Modulatoren und Verfahren zu ihrer Verwendung | |
DE69415694T2 (de) | Ionisch leitendes Mittel, System für den kathodischen Schutz von galvanisch aktiven Metallen und Verfahren und Vorrichgtung für dessen Anwendung. | |
DE69720057T2 (de) | Vorrichtung und verfahren zur erhöhung des transdermalen wirkstoffeflusses | |
DE69532477D1 (de) | Zusammensetzung, vorrichtung und verfahren zur verbesserten elektrotransport-wirkstoffabgabe | |
MX9704037A (es) | 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos. | |
WO1998057620A3 (en) | Inositol for modulation of immune response | |
SE9603725D0 (sv) | New teatment | |
WO1994017792A3 (en) | Compositions and methods for transdermal drug delivery | |
ATE201997T1 (de) | Zusammensetzung und verfahren zur verstärkung von elektrotransport-wirkstoffzufuhr | |
DE3271605D1 (en) | Improvements in or relating to electrotherapeutic apparatus | |
ATE262921T1 (de) | Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x | |
HUP0003347A2 (hu) | Transzdermális terápiás rendszer (TTS) hatóanyag leadásához és eljárás a bőrre történő alkalmazáshoz | |
PL339736A1 (en) | Method of protecting persons against contamination due to inadmissible oral taking toxic ingredients of a transdermal therapeutic system and transdermal therapeutic system containing a contaminating agent | |
IL135499A0 (en) | Bile acid salts of metals with physiogical action and use thereof in theraphy | |
MX9704035A (es) | 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0789589 Country of ref document: EP |